Beta Bionics, Inc.
BBNX
$29.38
-$0.62-2.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.25M | 23.24M | 17.64M | 20.44M | 16.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.25M | 23.24M | 17.64M | 20.44M | 16.71M |
| Cost of Revenue | 12.13M | 10.74M | 8.67M | 8.75M | 7.79M |
| Gross Profit | 15.12M | 12.50M | 8.97M | 11.69M | 8.91M |
| SG&A Expenses | 23.97M | 23.50M | 20.02M | 15.51M | 14.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.30M | 43.11M | 36.28M | 33.48M | 27.68M |
| Operating Income | -17.04M | -19.87M | -18.64M | -13.04M | -10.98M |
| Income Before Tax | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M |
| EBIT | -17.04M | -19.87M | -18.64M | -13.04M | -10.98M |
| EBITDA | -16.66M | -19.53M | -18.34M | -12.81M | -10.64M |
| EPS Basic | -0.33 | -0.39 | -0.93 | -2.72 | -1.46 |
| Normalized Basic EPS | -0.20 | -0.24 | -0.58 | -1.70 | -0.91 |
| EPS Diluted | -0.33 | -0.39 | -0.93 | -2.72 | -1.46 |
| Normalized Diluted EPS | -0.20 | -0.24 | -0.58 | -1.70 | -0.91 |
| Average Basic Shares Outstanding | 43.63M | 43.39M | 30.71M | 6.67M | 6.66M |
| Average Diluted Shares Outstanding | 43.63M | 43.39M | 30.71M | 6.67M | 6.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |